Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy

Completed · Phase 2

Conditions studied: Diarrhea, Gastrointestinal Complications, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: Cyclophosphamide may help control the symptoms of autoimmune enteropathy . PURPOSE: This phase II trial is studying how well cyclophosphamide works in treating young patients with severe autoimmune enteropathy.

Key facts

Study ID

NCT00258180

Run by

Johns Hopkins University

People needed

3

Starts

2005-08-15

Expected to finish

2009-02-24

Last updated by the study team

2019-04-16

Who can join

Age: 1 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.